Agios Pharmaceuticals Inc. (0HB0)
LSE
Real-time Data
07:00 AM
Day's Range
32.5052 wk Range
22.40Overview - 0HB0 - Agios Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
1.39B
P/E (Trailing)
‪11.22‬
Price / Sales (TTM)
‪0.07‬
Price / Book
‪1.92‬
EV / EBITDA
‪-3.07‬
Profitability
Profit Margin
‪47.44%‬
Operating Margin
‪-247.07%‬
Return on Assets
‪-22.24%‬
Return on Equity
‪-34.33%‬
Ownership
Shares Outstanding
58.17M
Float
50.01M
Held by Insiders
‪1.06%‬
Held by Institutions
‪112.34%‬
Price stats
Beta
‪0.58‬
50-Day Avg
‪26.18‬
200-Day Avg
‪24.83‬
Dividends
Frequency
Annual
Market Cap - 0HB0 - Agios Pharmaceuticals Inc.
Peers - 0HB0 - Agios Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
Profile Summary - 0HB0 - Agios Pharmaceuticals Inc.
About
Agios Pharmaceuticals Inc. is a biopharmaceutical company specializing in cellular metabolism to develop differentiated medicines for rare diseases, with a particular emphasis on classical hematology. The company focuses on creating potentially transformative small-molecule therapies targeting unmet medical needs in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
